Purinergic and pyrimidinergic receptors as potential drug targets
- 23 March 2000
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 59 (10) , 1173-1185
- https://doi.org/10.1016/s0006-2952(99)00341-x
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Therapeutic applications of ATP-(P2)-receptors agonists and antagonistsExpert Opinion on Therapeutic Patents, 1999
- Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivationNature, 1997
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- Neural Control of the Lower Urinary TractInternational Journal of Urology, 1997
- Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytesDrug Development Research, 1996
- ATP-binding cassette proteins as targets for drug discoveryTrends in Pharmacological Sciences, 1996
- Adenosine Diphosphate as an Intracellular Regulator of Insulin SecretionScience, 1996
- A unifying purinergic hypothesis for the initiation of painThe Lancet, 1996
- Identification of a Short Form of the P2xR1-Purinoceptor Subunit Produced by Alternative Splicing in the Pituitary and CochleaBiochemical and Biophysical Research Communications, 1995
- Ecto‐enzymes and metabolism of extracellular ATPDrug Development Research, 1994